Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
47,736,075
-
Share change
-
-142,974
-
Total reported value
-
$4,287,457,211
-
Put/Call ratio
-
113%
-
Price per share
-
$89.87
-
Number of holders
-
215
-
Value change
-
+$79,945,031
-
Number of buys
-
112
-
Number of sells
-
104
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q1 2020
As of 31 Mar 2020,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,736,075 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Artal Group S.A., STATE STREET CORP, ALKEON CAPITAL MANAGEMENT LLC, and TimesSquare Capital Management, LLC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.